Innovent Biologics, Inc. announces that preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates from its oncology pipeline will be presented at the American Association for Cancer Research Annual Meeting 2024.
Innovent Biologics, Inc. announces that preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates from its oncology pipeline will be presented at the American Association for Cancer Research Annual Meeting 2024.